| Bennett Y Cowan Jr, MD | |
|
271 Medical Park Blvd, Bristol, TN 37620-7455 | |
| (423) 968-2311 | |
| (423) 968-2312 |
| Full Name | Bennett Y Cowan Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 271 Medical Park Blvd, Bristol, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649263500 | NPI | - | NPPES |
| 3001112 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD0000009364 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bennett Y Cowan Jr, MD 271 Medical Park Blvd, Bristol, TN 37620-7455 Ph: (423) 968-2311 | Bennett Y Cowan Jr, MD 271 Medical Park Blvd, Bristol, TN 37620-7455 Ph: (423) 968-2311 |
News Archive
The American Lung Association in California released new data today showing significant public health benefits from pursuing a smart growth future for California. The American Lung Association data shows health benefits, including reduced asthma attacks and premature deaths linked to the Vision California "mixed growth" and "growing smart" scenarios in 2035 that include more compact, sustainable development patterns.
A new preclinical study on triple negative breast cancer (TNBC) reports that an experimental polo-like kinase 1 (PLK1) inhibitor shrank tumor four times more powerfully when used along with standard drugs than alone. The study, reported in the journal PLOS ONE, opens up a new door of opportunity for patients with this disease.
Among U.S. adults who were established smokers in the past five years, those who use e-cigarettes daily were significantly more likely to have quit cigarettes compared to those who have never tried e-cigarettes.
We have relied on body mass index (BMI), a ratio of height to weight, to categorize people as overweight and obese for decades. A new study, however, suggests the use of BMI may be leading us to underestimate the obesity rate.
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.
› Verified 1 days ago
Dr. Nafees Ameer Mohammed, MBBS Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 271 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-4800 Fax: 423-230-6905 | |
Rick Whiles, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd, Ste 3600, Bristol, TN 37620 Phone: 423-990-2414 | |
Dr. Jean Marie Mancini, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Ste 450w, Bristol, TN 37620 Phone: 423-968-3713 Fax: 423-986-7352 | |
Dr. Craig S Graul, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 104 Manchester Pl, Bristol, TN 37620 Phone: 423-573-1988 | |
Roger J Mcsharry, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 271 Medical Park Blvd, Bristol, TN 37620 Phone: 423-968-2311 Fax: 423-968-2311 | |
Steven Michael Tomski, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 240 Medical Park Blvd Ste 2000, Bristol, TN 37620 Phone: 423-990-5495 Fax: 423-990-2492 | |
Theodore Thompson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1220 Volunteer Pkwy, Bristol, TN 37620 Phone: 423-274-6610 Fax: 423-274-6619 |